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ABSTRACT 
All the present investigation an attempt has been made to study the formulation and evaluation of matrix tablet of Metformin HCL 
using natural mucilage of Cassia tora as a release retardant. The matrix tablet was formulated using different drug polymer ratio. 
The developed formulation of tablet was evaluated for pre-compression and post–compression method. The result of the pre-
compression parameter like Bulk density, tapped density, Carr’s index and Hausner’s ratio were found to be with the limits 
indicating good flow properties of the granules. Swelling index reveals that with increasing mucilage concentration there is increased 
swelling showing 61% for F-2 at the end of 5 h where as for F-3 it was around 89.9 % respectively. In- vitro drug release for F3 
formulation was found to be 75% at the end of 10 h. With increases in mucilage concentration the drug release from the matrix tablet 
got retarded. In- vitro drug release data obtained were fitted to various release model excess the possible mechanism of the drug 
release. The results of all these parameters are tabulated and depicted graphically in the result and discussion section. IR spectral 
studies revealed that the drug, polymer and excipients used were compatible.  Drug release profile of all formulation was plotted in 
different kinetics. The calculated regression coefficients showed a higher r2 value with higuchi equation (r2= 0.958). Hence the 
release data of the Tablet obeyed higuchi model and release the drug diffusion. 
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1. INTRODUCTION 
The growing industrial utility of these gums in the field 
of paper, textile, petroleum recovery and pharmaceutical 
industries has resulted in an impetus in India for 
intensified research on new sources of gums and their 
modified products. Cassia tora mucilage (CTM) derived 
from the seeds of Cassia tora Linn. Belonging to 
Caesalpiniaceae is a wild crop and grows in most parts 
of India as a weed and locally known as charota. A 
natural gelling agent which has industrial and food 
applications is made commercially from the seed.
1 
The 
goal of any drug delivery system is to provide a 
therapeutic amount of drug to the proper site in the body 
to achieve promptly and then maintain the desired drug 
concentration i.e. the drug-delivery system should 
deliver drug at a rate dictated by the needs of the body 
over a specified period of treatment.
2
 The two most 
important aspects of drug-delivery are spatial placement 
and temporal delivery of a drug. Spatial placement 
relates to the targeting a drug to a specific organ or 
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tissue, while temporal delivery refers to controlling the 
rate of drug delivery to the target tissue.
3,4
An 
appropriately designed controlled-release drug-delivery 
system can be a major advance towards solving these 
two problems Oral route is the most oldest and 
convenient route for the administration of therapeutic 
agents because of low cost of therapy and ease of 
administration leads to higher level of patient 
compliance.
5 
Sustained drug delivery system was aimed 
to release the medication in a prolonged rate to maintain 
plasma drug levels. The drugs having shorter half-life 
are suitable for the sustained drug delivery system.
6,7, 8 
Among the synthetic hydrophilic polymer considered as 
release retardant but these polymers are quite expensive 
and biodegradability is question able when compared 
with natural polymers. Two decades have witnessed a 
mammoth growth in development of drug delivery 
systems by using natural gum based matrices. Natural 
gums are biodegradable and nontoxic, which hydrate 
and swell on contact with aqueous media, and these have 
been used for the preparation of dosage form. 
9, 10 
Drug products designed to reduce the frequency of 
dosing by modifying the rate of drug absorption are 
available since many years. Regular research is going on 
for the use of naturally occurring biocompatible 
polymeric materials in designing of dosage forms for 
oral sustained release administration. Among various 
dosage forms, matrix tablets are widely accepted for oral 
sustained release (SR) as they are simple and easy 
formulate. Matrix system is the release system, which 
prolongs and controls the release of drug that is 
dissolved or dispersed. In fact, matrix is defined as a 
well composite of one or more drugs with a gelling 
agent i.e. hydrophilic polymer.
11,12, 13 
Metformin HCL, 
the only available biguanide, remains the first line drug 
therapy for patients with type 2 diabetes mellitus acts by 
decreasing hepatic glucose output and peripheral insulin 
resistance. It has relatively short plasma half-life, low 
absolute bioavailability.
14, 15 
2. MATERIALS AND METHODS 
2.1Materials 
Cassia tora seeds were collected from the forest of durg, 
Chhattisgarh, India. Metformin was obtained as gift 
sample from Active Pharmaceutical Ingredient. All other 
ingredients were of analytical grade and purchased from 
Samar chemical and SD Fine-chem Mumbai.  
2.3 Method 
Isolation of mucilage from Cassia tora seeds 
16, 17
 
The seeds from Cassia were manually cleaned to remove 
external materials like straw, dust and soil. The damaged 
and prematured seeds were separated out. The seed were 
crushed into in mixer. The crushed seed material soaked 
in water for 5–6 hours, boiled for 30 minutes and left to 
stand for 1 hour to allow complete release of the 
mucilage into the water. The mucilage was extracted 
using a multi-layer muslin cloth bag to remove the marc 
from the solution. Ethyl alcohol (three times the volume 
of filtrate) was added to precipitate the mucilage. The 
mucilage was separated, dried in an oven at 45ºC, 
collected, ground, passed through a # 80 sieve and stored 
in desiccator at 30ºC and 45% relative humidity before 
use. This mucilage was tested for following 
physicochemical properties. This mucilage was tested 
for following physicochemical properties. Chemical test, 
particle size, weight loss on drying, viscosity, ph, 
density, charring, swelling ratio, bulk density, 
compressibility percentage, angle of repose, Carr’s 
index. All values were found to be satisfactory.
 
2.4 Priminary phytochemical screening of isolated 
mucilage  
The phytochemical properties such as presence of 
carbohydrate, protein, flavanoida, sterols, alkaloids, 
tannins, saponins, fats and terpenoids were determined. 
2.5 Physicochemical properties of dried mucilage
 
The physicochemical properties such as solubility, pH, 
specific gravity and viscosity of dried CTM were 
determined at 20ºC. The loss on drying, total ash 
content, acid insoluble ash and water soluble ash were 
determined according to Ayurvedic Pharmacopoeia of 
India (A.P.I).
18, 19
  
2.6 Identification of drug sample of drug sample by 
using F.T.I.R:- 
Identification was done by FTIR spectrophotometer .for 
this small amount of drug sample (Metformin 
hydrochloride) and FTIR grade potassium bromide 
(KBr) were triturated in 1:100 ratios. Then required 
quantity was placed in sample holder and placed in the 
analytical compartment .the sample was scanned for 
4000 to 400 cm
-1
 in spectrophotometer .the spectra was 
match with standard reference spectrum and the 
principle peaks were matched with reference standard.
20 
2.7 Drug –excipients compatibility studies: 
Compatibility of excipients with metformin 
hydrochloride was studied by Fourier Transform 
Infrared Spectroscopy (Shimadzu). The FT-IR spectra of 
all combinations containing drug and one or more 
polymers also show the characteristic peaks same as that 
of the pure drug. The FT-IR spectrum of all the 
combinations containing drug and one or more polymer 
or gum shows same or slightly shift in peak values when 
compared with the characteristic peak values of pure 
drug .
21 
2.8 Preparation of calibration curve in 6.8 phosphate 
buffer:  
1. Preparation of buffers and reagents: 
PH 6.8 solution of phosphate buffer is prepared as: 250 
ml of 0.2 M Potassium dihydrogen orthophosphate and 
112 ml of 0.2 M NAOH is prepared and taken into 1000 
ml volumetric flask, and then volume up to 1000ml is 
adjusted with distilled water and pH is adjusted at 6.8 
using diluted NAOH. 
 2. Spectrum of metformin hydrochloride 
From the prepared stock solution, quantity of 0.5 ml is 
pipette into 100 ml volumetric flask. Using phosphate 
buffer solution pH 6.8, volume is being made till 100ml. 
The resulting solution containing 5 ug/ml was scanned 
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between 200 and 400 nm. The λ max was found to be 
233 nm. 
 3. Metformin hydrochloride calibration curve in pH 
6.8 phosphate buffer:- 
Accurately weighed quantity metformin hydrochloride 
(50 mg) was dissolved in little quantity of phosphate 
buffer solution pH, 6.8 and volume was made up to 100 
ml. appropriate. Appropriate aliquots were taken into 
different volumetric flasks and made up to 50 ml with 
pH, 6.8, solution of phosphate buffer so as to get drug 
concentrations of 2 to 10 µg/ml. the blank solution was 
scanned at 400 to 200 nm ,and maximum absorbance 
was found at 233 nm and all the absorbance was taken in 
same wavelength. 
 
Table 1: formulation chart of metformin HCL 
S.No Ingredients (mg) F1 F2 F3 F4 
1 Metformin hydrochloride  200 200 200 200 
2 Xanthan gum  20 20 20  
3 Ethyl cellulose  100 100 100 100 
4 HPMC 50 50 50 70 
5 Microcrystalline cellulose  80 70 60 80 
6 Cassia tora  30  40 50  30  
7 Isopropyl alcohol Q.S Q.S Q.S Q.S 
8 Mag –stearate 10 10 10 10 
9 Talc 10 10 10 10 
 
2.9 Preparation of metformin hydrochloride 
sustained release matrix tablet by wet granulation 
method:- 
Preparation of granules: 
Granules of metformin hydrochloride were prepared by 
wet granulation technology. All the corresponding 
powder (metformin hydrochloride, Ethyl cellulose, 
Xanthan gum, HPMC) were weight individually as per 
formulation chart .then the powder was added in 
ascending order and mixed with double cone blender for 
30 minutes. A soft mass was formed by using CTM 
paste .the wet mass was then passed through a sieve 
no.22.the prepared granules were then passed through a 
sieve no.44. Then calculated quantity of talk and 
magnesium stearate was added as mixed uniformly. 
These granules were then stored in an air tight container 
till further processing .
22,23 
2.10 Evaluation of pre-compression parameter  
Granules prepared by wet  granulation technology were 
evaluated for various rheological properties like bulk 
density, tapped density, Carr’s index, Hausner’s ratio 
and angle of repose by using standard procedure .all 
these properties were carried out in triplicate (n=3) and 
average values were reported.
24 
1. Angle of repose 
Angle of repose is defined as, “the maximum angle 
possible between the surface of pile of Powder and 
horizontal plane”. The angle of repose for powder of 
each formulation was determined by the fixed funnel 
method. A funnel was kept vertically in a stand at a 
specified height above a paper placed on a horizontal 
surface. The funnel bottom is closed and 10 gm of 
sample powder is filled in funnel. Then funnel was 
opened to release the powder on the paper to form a 
smooth conical heap, is found by measuring in different 
direction. The height of the heap was measured by using 
scale. The value of angle of repose is calculated by using 
the following formula: 
θ = tan-1 = h/r, 
Where, h- height of the heap, r-radius of the heap  
2. Tapped density  
Tapped density was determined by placing the granules 
in a measuring cylinder and the tapped volume (Vo) of 
granules after 100 tapping’s noted .the total mass of 
granules (M) was determined.tapped density was 
calculated by using the following formula.
25 
Tapped Density = Vb /Vf 
Where Vb – tapped volume, Vf – final tapped volume 
3. Bulk density 
A known quantity of powder was poured into the 
measuring cylinder carefully level the powder without 
compacting, if necessary and read the unsettled apparent 
volume, V0, to the nearest graduated unit. Calculate the 
bulk density, in gm per ml, by the formula,  
Bulk Density = m / V0, 
Where m - Unsettled, V0 - apparent volume 
4. Compressibility index  
The compressibility Index was calculated by using 
measured values for bulk density and tapped density as 
follows: 
Compressibility index =
 
[(Vt-Vb)/Vt] x100
 
Where Vt = tapped density, Vb = bulk density 
5. Hausner’s ratio:- 
The hausner’s ratio was calculated by using measured 
values for bulk density and tapped 
Density as follows: 
Hausner Ratio = Dt/Do 
Where Dt = tapped density, Do = bulk density 
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2.11 Evaluation of tablets
26,27
 
 
1. Thickness and Diameter: 
Thickness and diameter of tablets was determined using 
Vernier Caliper. Five tablets from 
Each batch was used, & average values were calculated. 
2. Hardness of the Tablet: 
Tablet hardness has been defined as, “the force required 
breaking a tablet in a diametric Compression test”. For 
each formulation, the hardness of three tablets was 
determined using Monsanto hardness tester. The tablet 
was placed in “Monsanto hardness tester ’’.the tablet 
was placed in Monsanto hardness tester vertically and 
the force was applied with the help of screw the end 
point was detected by breaking the tablet. 
3. Weight variation test: 
Twenty tablets were randomly selected and weighed to 
determine the average weight and were compared with 
individual tablet weight. The percentage weight 
variation was calculated as per Indian Pharmacopoeial 
Specification. Tablets with an average weight more than 
400 mg should not be more than ±5 %.this is an 
important process which comes under quality control 
test .according to standard in one batch all tablet should 
be in uniform weight .the weight variation test was 
performed with the help of digital weighing balance. 
From the one batch 20 tablets were selected randomly as 
sample and their individual weight was determined and 
average weight was determined .finally percentage 
deviation was calculated by the using following formula: 
             
                 –             
             
 × 100 
4. Friability test:- 
10 tablets from each batch were selected randomly 
selected from the batch as a sample and their collectively 
initial weight was determined.aal the tablet were placed 
in friabilator and rotated for 100 revolutions at 25 RPM. 
After rotation final weight was determined. The 
percentage of friability was calculated by following 
formula. According to standard the weight loss should 
not be more than 1%. 
Following formula was used to calculate the friability 
F = (1- W/Wo) × 100……………. (4) 
Where, Wo - Weight of tablet before test. 
W- Weight of tablet after test. 
             
                 –             
             × 100
 
5. Determination of drug content:- 
The drug content of metformin hydrochloride was 
determined with the help of ph 7.4 phosphate buffer 
solution .tablets were placed in 100 ml of ph 6.4 
phosphate buffer solution individually . It was kept for 
24 hours in room temperature and filtered. 1ml. of 
solution was withdrawn and diluted up to 10 ml with the 
help of ph 6.4 phosphate buffer solution and absorbance 
was recorded by UV–Visible spectrophotometer at 233 
nm. Finally the drug content was determined by using 
calibration curve. 
6. in –vitro dissolution study:- 
Dissolution study of metformin hydrochloride tablet was 
performed with the help of united states pharmacopoeia 
(USP) XXIII dissolution testing apparatus I(basket type 
).900 ml of phosphate buffer solution PH6.4 was taken 
in dissolution vessel as media and warmed at 37 
±0.5C.the media was stirred at 50Mrpm. 5ml sample 
from dissolution  vessel as media was added maintain 
the shrink condition .the sample was diluted up to 10 ml 
and absorbance of these solution measured at 237 nm 
using the equation obtained from a standard calibration 
curve . Finally graph was plotted between time in X axis 
and cumulative percentage drug release in y axis. 
 2.12 Drug release kinetics 
6 
The dissolution data obtained were fitted into following 
kinetic model. This was to determine the mechanism of 
drug release. 
1. Zero-Order Kinetics: 
Zero order as cumulative amount of drug released vs. 
time,                      C = K 0 t 
Where K0 is the zero-order rate constant expressed in 
units of concentration/time and t is the time in hours. A 
graph of concentration vs time would yield a straight 
line with a slope equal to K0 and intercept the origin of 
the axes.
28,29 
2. First Order Kinetics: 
The application of this model to drug dissolution studies 
used to describe absorption and/or elimination of drugs. 
To study the first order release rate kinetics the release 
rate data were fitted to the following equation 
Log Qt = log Q0 + K1t / 2.303 
Q t is the amount of drug released in time t 
Q0 is the initial amount of drug in the solution K1 is the 
first order release constant. 
3. Higuchi Model: 
Higuchi developed several theoretical models to study 
the release of water soluble and low soluble drugs 
incorporated in semi-solid and/or solid matrixes. 
Mathematical expressions were obtained for drug 
particles dispersed in a uniform matrix behaving as the 
diffusion media, the equation is             Qt = KH.t
1/2
 
Qt is the amount of drug released in time t KH is 
Higuchi dissolution constant. Higuchi describes drug 
release as a diffusion process based in the Fick’s law, 
square root time dependent.
30,31 
4. Korsmeyer and Peppas Model: 
This model is generally used to analyze the release of 
pharmaceutical polymeric dosage forms, when the 
release mechanism is not well known or when more than 
one type of release phenomena could be involved. 
Mt / M = K.t
n 
Mt /M is the fraction of drug release K is the release 
constant 
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t is the release time n is the diffusion exponent for the 
drug release that is dependent on the shape of the  matrix 
dosage form. 
Where Mt/M∞ is the fractional solute release, t is the 
release time, K is a kinetic constant characteristic of the 
drug/polymer system, and n is an exponent that 
characterizes the mechanism of release of tracers. For 
cylindrical matrix tablets, if the exponent n = 0.45, then 
the drug release mechanism is Fickian diffusion, and if 
0.45 < n < 0.89, then it is non-Fickian or anomalous 
diffusion. An exponent value of 0.89 is indicative of 
Case-II Transport or typical zero-order release.
32 
2.13 Polymer Swelling or Water Uptake studies 
 
The swelling behaviour of batches F2, F3, was studied. 
The tablets (n=3) were kept in Petri dish containing 
25ml distilled water at 37±2°C at selected time points, 
the tablets were withdrawn, wiped with tissue paper, and 
weighed. The percent water uptake by the tablet was 
calculated using the following formula: 
Percentage water uptake = 100 × [Wt - W0/W0] 
Where, Wt was weight of tablet at time t and W0 was 
initial weight of the tablet 
3. RESULT AND DISCUSSION 
 3.1 Preformulation studies  
The drug sample was evaluated for its colour and odour. 
Table 2: Identification of Drug 
S. No Parameter  drug 
1 Color White  
2 Odour odourless 
3 Taste  tasteless 
4 Appearance Crystalline powder 
 
3.2 Determination Melting point: 
 Melting point of the drug sample was determined by 
capillary method by using melting point apparatus. 
Table 3: Melting Point of Pure Drug 
S. No Reported M.P. Observed M.P. 
1 222-226
0
c 222-224
0
c 
3.3 Solubility study: 
 The solubility of the metformin HCL was determined 
by adding excess amount of drug in the solvent and 
equilibrium solubility was determined by taking 
supernated and analyzing it on shimadzu uv, double 
beam spectrophotometer .the solubility of the metformin 
HCL was found to be slightly soluble in water and freely 
soluble in acetone. 
Table 4: Solubility of metformin HCL in different 
solvent 
S. No Medium found  % found Mg/100ml 
1 Water 99.58% 99.58 
2 0.1N HCL 100.10% 100.10 
3 Phosphate 
buffer ph(6.8) 
99.65% 99.65 
 
3.4 Preliminary Phytochemical Screening of Isolated 
Mucilage  
The Phytochemical screening of natural mucilage 
confirmed polysaccharides in nature [Table 5]. The 
physicochemical and microbiological properties of CTM 
were determined. The CTM Completely soluble in warm 
water, swelling index, viscosity obtained 33% and 20-
100cps. The pH of the mucilage was found to be 5.6-6.5 
were very near to neutral it may be less irritating on 
gastrointestinal tract and hence gum is suitable for 
uncoated tablet. 
Table 5: Preliminary Phytochemical Screening of 
Isolated Mucilage 
S.No Active constituent  CTM mucilage 
1 Carbohydrate + 
2 Protien - 
3 Flavanoids - 
4 Tannins - 
5 Saponins - 
6 Sterol - 
7 Alkaloids - 
8 Terpenoids - 
9 Protien + 
10 Starch - 
11 Fats + 
+present, - absent
Table 6:  physicochemical properties of CTM mucilage 
S. No. Parameter Result 
1 Appearance Yellow white powder 
2 Solubility Soluble in cold water and hot water forming viscous colloidal solution 
3 Swelling index (%) 33.0 ± 0.15 
4 pH 5.5 - 6.5 
5 Hot viscosity (1.0%w/v solution) 20 -100 cps 
All values are mean ± S.D. for n=3  
Table 7:  Physicochemical properties of dried mucilage 
S.No Properties Result Type of flow 
1 Angle of repose  25
 
Good flow
 
2 Bulk density  0.600 ± 0.05 Good  
3 Tapped density 0.625 ± 0.04 Good  
4 Compressibility index 7.97± 0.78 Excellent 
All values are mean ± S.D. for n=3  
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3.5 FTIR spectrum of metformin HCL 
FTIR spectroscopy was performed for the identification 
of pure drug. The spectra was obtained from the FTIR 
spectrometer  at the wavelength from  4000cm
-1 
to 400 
cm
-1 
is present  at figure no and the characteristic peaks 
which was obtained  is present in table no. 
 
 
Figure 1: FTIR Spectra of Pure Drug Sample of Metformin HCL 
Table 8: Comparison of reference spectrum with drug sample 
FTIR Band of METFORMIN HCL FTIR Band Of Drug Sample Functional Group 
3370 3367.71 NH- 
3290 3294.42 NH- 
3174 3170.97 C-H 
1420 1418 C-H 
1477 1470.47 C=H 
 
3.6 FTIR Spectra of CTM 
 
Figure 2: FTIR Spectra of CTM 
Drug – excipients compatibility study: 
 
Figure 3: FTIR Spectra Ratio of CTM and Metformin HCL 
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Figure 4:  FTIR spectra of Metformin HCL tablet formulation 
 
Figure 5: Drug – polymer compatibility study 
Table 9: FTIR Interpretation of Pure Drug with Excipients 
FT-IR band of drug 
sample (cm
-1
) 
FT-IR band of different formulaton (cm
-1
) 
F1 F2 F3 
3367.71 3367.71 3367.71 3368.96 
3294.42 3295.06 3295.06 3295.06 
1470.47 1447.23 1447.23 1447.23 
 
3.7 Standard calibration curve of Metformin HCL: 
 
Figure 6:  Standard Calibration Curve of Metformin HCL in Phosphate Buffer Ph 6.8 
Table 10:  Preformulation Evaluations of Metformin HCL Granules 
y = 0.0807x - 0.0028 
R² = 0.9999 
0 
0.2 
0.4 
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0.8 
1 
0 2 4 6 8 10 12 
A
B
S
O
R
B
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C
E
  
CONCENTRATION μg/ml  
Calibration curve of Metformin HCL 
S. No  
Formulation  
code  
Bulk Density 
(g/ml) ±S.D 
Tapped Density  
(g/ml)± S.D 
Compressibility 
Index (%) ±S.D 
Hausner’s 
Ratio ±S.D 
Angle of repose  
±S.D  
1 F-1 0.547±0.018 0.55±0.57 7.33±3.550 1.07±0.0416 27.9±1.34 
2 F-2 0.54±0.0208 0.586±0.011 7.33±3.55 1.253±0332 26.40±0.70 
3 F-4 0.53±0.0251 0.533±0.057 6.9±7.078 1±0.149 26.55±0.915 
4 F-11 0.53±0.0264 0.556±0.053 5.58±6.42 0.97±0.110 27.01±0.455 
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Table: 11 Evaluation of Metformin HCL Tablet 
All values are mean ± S.D. for n=3 
 
3.8 Drug Content  
Table 12: Drug Content of Different Formulation 
S.No  Formulation code  Drug contant (%) 
1 F1 99.89 
2 F2 99.53 
3 F3 99.44 
 
Among the different formulation the drug content of 
tablet 99.53 % of metformin HCL 500 mg. 
 
Figure 7:  After 3 Hours of Swelling (F1-F3) 
 
 Figure 8: After 5 hours of swelling (F2-F3) 
 
Figure 9:  After 10 Hours of Swelling (F2-F3) 
 
Figure 10:  Relationship between Swelling index and 
Time (Batch F2 to F3) 
 
3.10 In vitro drug release: in vitro drug release of 
different formulation is shown in Figure 11. 
 
 
Figure 11:  drug release kinetics of Different 
Formulation
 
 
3.11 Drug release kinetics of different formulation:- 
Table 13:  Drug Release Kinetics of Different Formulation 
F. Code Zero  order 
R
2 
First Order R
2 
 value Higuchi Equation R
2 
Korsmeyer Modle R
2 
Values 
F1 0.856 0.824 0.838 0.756 
F2 0.900 0.900 0.976 0.566 
F3 0.951 0.951 0.958 0.550 
F4 0.927 0.926 0.920 0.729 
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Time In Hour 
Drug Release Kinetics  
F1 
F2 
F3 
F4 
Formulation  Thickness 
(mm) 
Hardness 
(kg/cm
2
) 
Friability 
(%) 
Average  
weight(mg) 
Weight  
variation 
F1 5.85±0.045 6±0.854 0.146±0.08 506.1±367 Pass 
F2 5.73±0.06 6.4±0.96 0.109±0.038 503.1±1.95 Pass 
F3 5.81±0.102 5.66±0.51 0.105±0.046 506.1±3.66 Pass 
F4 5.79±0.08 6.26±0.90 0.146±0.087 503.2±2.05 Pass 
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Figure 12: Zero Order Kinetic Models of 
Formulation F1to F4 
 
Figure 13: First Order Kinetic Models of 
Formulation of F1, F2, F3 and F4 
 
Figure 14: Higuchi Models of Formulation F1 to F4 
 
 
Figure 15: Korsmeyes Peppas Kinetic Models of 
Formulation F1, F2, F3 and F4
 
3.12 Accelerated stability studies 
The stability study of optimized batch was carried out at 
25°C/60% RH, 30°C/65% RH and 40°C/75% RH as per 
ICH guidelines. The tablets of all formulation were 
found to be stable at such condition and other 
parameters were found to be unaffected and were under 
pharmacopoeial limits. 
4. DISCUSSION 
In preformulation studies drug sample was procured and 
identified by comparing the FTRI SPECTRUM with 
standard reference, and the sample have the entire peak 
according to standard reference .for the identification of 
the drug their melting point and solubility test was 
determined in which sample result was performed 
according to standard. The drug compatibility study was 
also performed with the help of FTIR, and there not any 
chemical interaction was found between drug and 
excipients at any formulation. Bulk density of the 
developed formulation F1 to F4 varied from 
0.53±0.0251 gm/ml 0.54±0.0208, the tapped densities 
were varied from in the range of 0.533±0.0577 to 
0.586±0.011 .the difference between tapped density and 
bulk density were near about same of all formulation 
except F4 formulation. The compressibility index value 
was found to be range of 5.58±6.42 to 7.33±3.550. these 
finding indicated that the powder mixture exhibited 
Excellent flow properties .The result of Hausner’s Ratio 
were ranged from 0.97±0.110 to 1.253±0332, which 
indicate good flow properties of F3 formulation and F2 
formulation good flow properties. The angle of repose 
was ranged between 26.40±0.70 to 27.9±1.34, which 
indicates good flow property of powder.Thickness of the 
developed formulation varied from 5.73±0.06 mm to 
5.85±0.045, which was uniformly throughout the 
batches and within the permissible limit .hardness varied 
from 5.66±0.51to 6.4±0.96 kg/cm
2
 which indicates 
tablets possess sufficient strength.  The friability of all 
formulation was found to be a minimum from 
0.146±0.08 to 0.109±0.038 %. Among all the 
formulation the friability of F1, F2, F3, F4 batch were 
good friability. The average weight of twenty tablets 
was calculated for each batch which varied from 
503.1±1.95 to 506.1±367 mg , the percent deviation of 
all the formulations comply with weight variation test.In 
the formulation no F-1 EC 20% and HPMC 10%, 
xanthan gum 4% was using in CTM 6%, as decreased 
the concentration of polymer the release rate increase 
and only 80% drug release in 10 hrs. In the preparation 
of the tablets (F2), combination of HPMC and ethyl 
cellulose was used in 3 xanthane gum , Microcrystalline 
cellulose , Cassia tora , talc and  magnesium stearate  
was used , and tablet were prepared by wet granulation 
technique , in which 500 mg  strength tablet was 
prepared with help of 9 mm diameter punch size , and 
y = 4.744x + 17.556 
R² = 0.9003 
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the thick ness was found to be 6.5mm , several batch 
were prepared to sustained the release of drug. 
When dissolution study was performed for the tablet , 
due to presence of xanthane gum HPMC ,EC  and CTM 
using tablet was hydrated and swelled upon contact with 
aqueous media and released rate F-2 and F-3 
formulation 62-74.25 % drug release in 10 hrs the 
release kinetics was determined for the batches and 
formulation followed the higuchi  model . The 
calculated regression coefficients showed a higher r
2
 
value with higuchi model (r
2
= 0.958).  Hence the release 
data of the Tablet obeyed Higuchi model and release the 
drug diffusion mechanism. For the above study it was 
conclude that sustained release matrix tablet using CTM 
can be prepared successfully in industrial scale. 
CONCLUSION  
The present research work was undertaken with an 
abjective to  reparation , formulation and evaluation 
metformin HCL tablet by altering polymer and CTM 
Mucilage (HPMC, EC, XANTHAN GUM AND 
CASSIA TORA MUCILAGE)  as a trial , for treatment of 
Antidiabetic .primarily were prepared using wet 
granulation technique , and were evaluated as 
pharmacopoeial specification experimental work till 
done.
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